The Efficacy and Safety of IBI351, Cetuximab β Combined With FOLFIRI as First-line /IBI351, Cetuximab β as Second-line in the Treatment of KRAS G12C-mutated Metastatic Colorectal Cancer
PHASE2
This is an open-label, multicenter, single-arm Phase II clinical study, div...
Status
Enrolling By Invitation
Location
The Second Affiliated Hospital, School of Medicine, Zhejiang University